EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy

Ramen Munir Baloch, Yannick Béjot

Acta Neurologica Scandinavica · 2026-01 · 2026 (1)

DOI: 10.1155/ane/1432436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 07.08.2026. Verfasst von Ramen Munir Baloch und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Fatigue adversely affects quality of life after stroke. This study is aimed at assessing the prevalence of poststroke fatigue at 6 months and its determinants in patients with acute ischemic stroke treated with revascularization therapy.

Methods

Consecutive ischemic stroke patients treated with intravenous thrombolysis and/or mechanical thrombectomy were enrolled. Sociodemographic, clinical, and ischemic lesion characteristics were collected at baseline. Fatigue was assessed at 6‐month follow‐up using the Fatigue Severity Scale (FSS), along with functional outcome, anxiety, and depression. Factors associated with poststroke fatigue were evaluated in the overall cohort and in patients with supratentorial hemispheric stroke using logistic regression models.

Results

Among 900 enrolled patients, 413 survivors had available fatigue assessment (mean age: 69.2 ± 14.1 years, 52.3% men, median NIHSS score: 9 [IQR: 5–15]). Poststroke fatigue (FSS score ≥ 36) was observed in 161 patients (39%). In the overall cohort, fatigue was independently associated with depression (OR = 5.78, 95% CI: 2.68–12.4) and anxiety (OR = 2.90, 95% CI: 1.52–5.51), whereas being single was negatively associated with fatigue (OR = 0.30, 95% CI: 0.09–0.99). A marginal association was observed with cerebellar stroke location (OR = 11.0, 95% CI: 0.88–137.6). In patients with supratentorial hemispheric stroke, fatigue was independently associated with hypertension (OR = 2.25, 95% CI: 1.13–4.47), right‐sided lesion (OR = 2.08, 95% CI: 1.13–3.83), depression (OR = 5.35, 95% CI: 2.08–13.7), and anxiety (OR = 3.10, 95% CI: 1.42–6.74).

Conclusions

Poststroke fatigue remains a frequent and clinically meaningful outcome in patients with ischemic stroke treated with revascularization therapy and is strongly associated with psychological factors and right hemispheric location. Whether specific therapeutic interventions may reduce the burden of this symptom warrants further investigation. Trial Registration ClinicalTrials.gov identifier: NCT02856074

Zitieren

APA

Baloch, R. M., & Béjot, Y. (2026). Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/1432436

Vancouver

Baloch RM, Béjot Y. Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/1432436

BibTeX
@article{Baloch2026,
  author = {Baloch, Ramen Munir and Béjot, Yannick},
  title = {Prevalence and Determinants of Poststroke Fatigue in Patients Treated With Acute Revascularization Therapy},
  journal = {Acta Neurologica Scandinavica},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ane/1432436}
}
Kostenlos starten →